656257-46-4

Usage

Uses

Used in Organic Synthesis:
1-(2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-pyrrolidine is used as a key intermediate in the synthesis of complex organic molecules, particularly in the development of new pharmaceuticals, agrochemicals, and materials. Its unique structure allows for versatile chemical reactions and modifications, enabling the creation of a wide range of compounds with diverse properties and applications.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 1-(2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-pyrrolidine is used as a building block for the design and synthesis of novel drug candidates. Its unique molecular features can be exploited to target specific biological pathways and receptors, potentially leading to the discovery of new therapeutic agents with improved efficacy and selectivity.
Used in Agrochemical Research:
1-(2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-pyrrolidine is utilized in the research and development of new agrochemicals, such as pesticides and herbicides. Its unique structure and reactivity can be harnessed to create compounds with enhanced activity against pests and weeds, while minimizing potential environmental and health risks.
Used in Materials Science:
In the field of materials science, 1-(2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-pyrrolidine is employed as a component in the synthesis of advanced materials with specific properties, such as high thermal stability, electrical conductivity, or optical characteristics. Its incorporation into material systems can lead to the development of innovative materials for various applications, including electronics, energy storage, and sensing technologies.
Used as a Research Reagent:
1-(2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-pyrrolidine is used as a reagent in research laboratories for the synthesis of other organic compounds. Its unique structure and reactivity make it a valuable tool for chemists in exploring new synthetic pathways and developing novel chemical transformations.

Upstream product

• 1081-73-8 1-[2-(4-bromophenoxy)ethyl]pyrrolidine 
• 73183-34-3 bis(pinacol)diborane 
• 5050-41-9 N-(2-chloroethyl)-pyrrolidine 
• 269409-70-3 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol 
• 2955-88-6 1-pyrrolidineethanol 

Relevant academic research and scientific papers

BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS

This invention is a benzothiophene estrogen receptor modulator or its pharmaceutically acceptable salt, N-oxide, isotopic derivative or prodrug thereof or a pharmaceutically acceptable composition thereof to treat an estrogen-related medical disorder. The invention also includes a combination thereof with another active agent such as a CDK inhibitor, including a CDK4/6 inhibitor, to treat a disorder mediated by the estrogen receptor, as described in more detail herein.

Synthesis of Novel Hydroxymethyl-Substituted Fused Heterocycles

Examples of hydroxymethylated analogues of heteroaryl cores such as quinazolin-4-ones, isoquinolin-1(2H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, chromen-4-ones and pyrrolo[2,1-f][1,2,4]triazin-4(3H)-ones are sparse or non-existent in the scientific literature. We have demonstrated that such compounds are accessible by using standard procedures from readily available raw materials.

PYRAZOLOPYRIMIDIN-2-YL DERIVATIVES AS JAK INHIBITORS

New pyrazolopyridmiin-2-yl derivatives are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

CHEMICAL COMPOUNDS 637

The present invention provides a compound of a formula (I), wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.